MIM
ZYNE

MetLife Investment Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

MetLife Investment Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,100
Closed -$150K – 2415
2019
Q2 		$150K Buy
+11,100
New +$150K ﹤0.01% 2189